FDA Approved: ALPRAZOLAM — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved a supplemental application for Alprazolam from Natco Pharma USA LLC under an ANDA, updating the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)